Academic health science centres
From: Doctors in Denial
Describes and analyzes the money received by academic health science centres from the pharmaceutical industry for research and the conflicts that this money may create.
Joel Lexchin MD
JOEL LEXCHIN, MD, is an internationally-recognized expert in pharmaceutical policy. He received his MD from the University of Toronto and has spent over thirty years working as an emergency physician in the Toronto area. He taught health policy and is a Professor Emeritus in the School of Health Policy and Management at York University. He has been an advocate for change in pharmaceutical policy for thirty-five years, has appeared before numerous parliamentary committees, and has authored or co-authored over 150 articles about all aspects of how medicines are developed and used.